CDEK
← All organizations

EUSA

For profitContributed to NME

Also known as: EUSA Pharma | EUSA Pharma, Inc. | EusaPharma (UK) Limited | EUSA Pharma (UK) Limited | EUSA SAS

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Apr 1, 2008

First marketed drug

Nov 18, 2011

First NDA

Nov 18, 2011

Last known activity

Jul 1, 2024

Acquired by Jazz Pharmaceuticals on Apr 26, 2012

Timeline

2000s

  1. Mar 1, 2005

    EUSA— Founded

  2. Jan 1, 2007

    Opi Pharmaceuticals— Acquired

  3. Jan 1, 2008

    Cytogen— Acquired

2010s

  1. Nov 18, 2011

    erwinia asparaginase— NDA Organization

  2. Apr 26, 2012

    Jazz Pharmaceuticals— Acquired By

Drugs by trial phase (22 distinct, 15 trials)

Phase 4 (2 own, 0 via acquisition)

Phase 3 (1 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (1)

Subsidiaries (2 direct, 3 total across the full acquisition tree)

Recent trials (8)

Details

Founded
Hemel Hempstead, GB Mar 1, 2005
First NDA
Nov 18, 2011
Last known activity
Jul 1, 2024

Designations held

  • Orphan drug

Notes

Acquired by Cytogen 9 May 2008